Literature DB >> 29793646

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.

Philip Bonomi1, Gideon Blumenthal2, Andrea Stern Ferris3, David J Stewart4, Wendy K D Selig5, Lee M Krug6, Jeff Allen7, Gwynn Ison2, Corey J Langer8, Allen Melemed9, Lauretta Odogwu2, Upal Basu Roy3, Alan Sandler10.   

Abstract

Mesh：

Year:  2018        PMID： 29793646     DOI： 10.1016/j.jtho.2018.02.013

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations.

Authors:  Karen M Winkfield; Jeanne M Regnante; Ellen Miller-Sonet; Evelyn T González; Karen M Freund; Patricia M Doykos
Journal:  JCO Oncol Pract       Date:  2021-01-18

2.  The need for speed in advanced non-small cell lung cancer: A population kinetics assessment.

Authors:  David J Stewart; Donna E Maziak; Sara M Moore; Stephanie Y Brule; Marcio Gomes; Harman Sekhon; Carole Dennie; Bryan Lo; Michael Fung-Kee-Fung; John-Peter Bradford; Martin Neil Reaume
Journal:  Cancer Med       Date:  2021-11-11       Impact factor: 4.452

3.  The effect of prior cancer on non-small cell lung cancer trial eligibility.

Authors:  Michael Herman; Zhihui Liu; Frances A Shepherd; Natasha Leighl; Geoffrey Liu; Penelope A Bradbury
Journal:  Cancer Med       Date:  2021-06-18       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.